Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep biology and chemistry expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medication

Go
       

Approved in the U.S.:
Iclusig® (ponatinib)

An ARIAD-developed medicine

Learn more See full prescribing information, including BOXED WARNING.
ARIAD Corporate Video
 
ARAID

A remarkable place doing remarkable work

ARIAD: dedicated to making a difference for cancer patients

Learn more

A unique, highly targeted approach to cancer

Our research & development program

Learn more

News & Features

Latest News

6/18/13

ARIAD Honored with Gold Stevie® Awards as Pharmaceutical Company of the Year at 2013 American Business Awards

Read More

6/13/13

ARIAD Announces Webcast of Its Annual Shareholders Meeting

Read More

ARIAD PASS™ Program

ARIAD Pass Logo

Providing comprehensive services to help patients ACCESS, AFFORD and ADHERE to treatment.
Learn more

Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue